CNS Therapeutics Receives $50,000 New Financing Round

  • Feed Type
  • Date
    4/28/2011
  • Company Name
    CNS Therapeutics
  • Mailing Address
    332 Minnesota Street Saint Paul, MN 55101
  • Company Description
    CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics.
  • Website
    http://www.gablofen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.